drugset / Trial / NCT04184258
Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells
Phase 1/2
Completed
7 enrolled
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Belarusian State Medical University · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Treatment of systemic lupus erythematosus with pooled allogenic mesenchymal stem cells
Timeline
- Start
- 2019-07-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pooled mesenchymal stem cell | Cell therapy | — | — |